| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Opus Genetics, Inc. | Chief Scientific & Dev. Ofc. | Common Stock | 125,807 | $144,678 | $1.15 | 13 Mar 2025 | Direct |
| Opus Genetics, Inc. | Chief Scientific & Dev. Ofc. | Employee Stock Option (right to buy) | 52,500 | 13 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | 13 Mar 2025 | 2 | $0 | 4 | Chief Scientific & Dev. Ofc. | 17 Mar 2025, 20:50 |
| IRD | Opus Genetics, Inc. | 13 Feb 2025 | 1 | -$5,971 | 4 | Chief Scientific & Dev. Ofc. | 18 Feb 2025, 16:04 |
| OCUP | Ocuphire Pharma, Inc. | 22 May 2024 | 1 | $6,177 | 4 | Chief Scientific & Dev. Ofc. | 24 May 2024, 16:07 |
| OCUP | Ocuphire Pharma, Inc. | 12 Feb 2024 | 2 | $0 | 4 | Chief Scientific & Dev. Ofc. | 14 Feb 2024, 18:35 |
| OCUP | Ocuphire Pharma, Inc. | 12 Feb 2024 | 0 | $0 | 3 | Chief Scientific & Dev. Ofc. | 14 Feb 2024, 18:29 |